Literature DB >> 22884758

Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors.

Anilga Moradkhani1, Linda J Beckman, James H Tabibian.   

Abstract

BACKGROUND AND AIMS: Individuals with inflammatory bowel disease (IBD) have impaired health-related quality of life (HRQOL). Managing HRQOL is increasingly becoming an important treatment consideration in IBD. Understanding factors that impact HRQOL may facilitate interventions to improve HRQOL and overall IBD management. We hypothesized that psychosocial variables, namely perceived stress, perceived social support, and knowledge, would be associated with HRQOL among individuals with IBD.
METHODS: A total of 134 adults with IBD were recruited online from IBD support groups. HRQOL was measured using the inflammatory bowel disease questionnaire (IBDQ). Perceived stress, perceived social support, and knowledge of IBD were measured using standardized questionnaires. Clinical and demographic variables were gathered through a 16-item study questionnaire. Univariate analyses were conducted to determine which variables were associated with HRQOL, and those that were statistically significant were entered into a multivariate regression model.
RESULTS: Results from univariate analyses revealed significantly lower HRQOL in individuals who: reported higher perceived stress, higher number of previous hospitalizations and relapses, lower perceived support, lower income, were unemployed, and were female. Multivariate analyses revealed that the variables most strongly associated with HRQOL were perceived stress (p<0.001), number of previous IBD relapses (p<0.001), gender (p<0.001), and perceived social support (p<0.05).
CONCLUSION: Individuals with IBD who report higher perceived stress, lower perceived social support, greater number of relapses, or are female may be at increased risk for decreased HRQOL. Prospective studies should investigate how interventions addressing these factors may lead to improved HRQOL.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22884758     DOI: 10.1016/j.crohns.2012.07.012

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  32 in total

1.  Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.

Authors:  Anilga Tabibian; James H Tabibian; Linda J Beckman; Laura L Raffals; Konstantinos A Papadakis; Sunanda V Kane
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

2.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

3.  Validation of the Crohn's and Ulcerative Colitis questionnaire in patients with acute severe ulcerative colitis.

Authors:  Hayley A Hutchings; Laith Alrubiay; Alan Watkins; W-Y Cheung; Anne C Seagrove; John G Williams
Journal:  United European Gastroenterol J       Date:  2016-09-20       Impact factor: 4.623

4.  Cytokine Genetic Variants and Health-Related Quality of Life in Crohn's Disease: An Exploratory Study.

Authors:  Mitchell R Knisely; Yvette P Conley; Eva Szigethy
Journal:  Biol Res Nurs       Date:  2019-07-04       Impact factor: 2.522

Review 5.  Mucosal Healing in Crohn's Disease: Bull's Eye or Bust? The "Relative" Con Position.

Authors:  Mahmoud Mosli; Turki Alameel; Ala I Sharara
Journal:  Inflamm Intest Dis       Date:  2021-10-20

6.  Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.

Authors:  Grace Wang; Parul Tandon; Nicole Rodriguez; Lindsy Ambrosio; Reed T Sutton; Levinus A Dieleman; Karen I Kroeker; Vivian Huang
Journal:  Dig Dis Sci       Date:  2022-08-05       Impact factor: 3.487

Review 7.  Health-Related Quality of Life of Patients Treated with Biological Agents and New Small-Molecule Drugs for Moderate to Severe Crohn's Disease: A Systematic Review.

Authors:  Hasan Aladraj; Mohamed Abdulla; Salman Yousuf Guraya; Shaista Salman Guraya
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

Review 8.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

9.  Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease.

Authors:  Laura Katz; Dean A Tripp; Mark Ropeleski; William Depew; J Curtis Nickel; Stephen Vanner; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2016-03

10.  Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease.

Authors:  Yao Wei; Weiming Zhu; Jianfeng Gong; Dong Guo; Lili Gu; Ning Li; Jieshou Li
Journal:  Gastroenterol Res Pract       Date:  2015-06-04       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.